Journal article icon

Journal article

Early cost-effectiveness analysis of a novel rapid diagnostic test for tuberculosis in rural Philippine settings

Abstract:
Tuberculosis disproportionately affects low- and middle-income countries (LMICs), where gold standard molecular diagnostic assays like Xpert MTB/RIF are relatively frequently inaccessible. A novel rapid molecular diagnostic test (nLRDT), which can test tongue swab samples, and is more suitable for decentralised primary healthcare settings, has been developed and is currently undergoing preclinical validation. This study evaluated the early cost-effectiveness of this nLRDT vs. Xpert MTB/RIF for diagnosing pulmonary tuberculosis in rural Philippine primary healthcare settings. A hybrid decision tree and Markov model-based cost-effectiveness analysis was conducted from health provider and societal perspectives. Parameters were taken from relevant literature, national-level data, and expert opinion. Costs were expressed in 2024 US dollars and cost-effectiveness evaluated by comparing incremental cost-effectiveness ratios with willingness-to-pay threshold estimates. An estimated willingness-to-pay (WTP) threshold of $1,357 per quality-adjusted life year (QALY) was used. The nLRDT was cost-effective with sputum samples, from both perspectives, with net monetary benefits (NMBs) of $26.62 (societal perspective) and $19.21 (provider perspective) at the WTP threshold of $1,357. Similarly, the nLRDT was estimated to be cost-effective for tongue swab samples from both perspectives, with NMBs of $43.81 (societal) and $24.79 (provider). Sensitivity and scenario analyses identified the specificity of nLRDT as the key driver of cost-effectiveness, with cost-effectiveness maintained at greater WTP thresholds and varying combinations of test performance characteristics. Our findings suggest the nLRDT can be a cost-effective diagnostic tool in rural Philippines, and possibly other similar, contexts. This has positive research, industry, and policymaking implications.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1371/journal.pgph.0005364

Authors

More by this author
Institution:
University of Oxford
Oxford college:
Oriel College
Role:
Author
ORCID:
0009-0001-5411-9723
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-7970-039X


More from this funder
Funder identifier:
https://ror.org/029chgv08


Publisher:
Public Library of Science
Journal:
PLOS Global Public Health More from this journal
Volume:
5
Issue:
10
Article number:
e0005364
Publication date:
2025-10-28
Acceptance date:
2025-10-06
DOI:
EISSN:
2767-3375
ISSN:
2767-3375


Language:
English
Pubs id:
2308752
Local pid:
pubs:2308752
Source identifiers:
3418437
Deposit date:
2025-10-29
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP